Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.39M Sell
47,504
-32,304
-40% -$2.84M 1.33% 23
2026
Q1
$7.67M Buy
79,808
+21,187
+36% +$1.87M 2.64% 14
2025
Q4
$5.5M Buy
58,621
+14,511
+33% +$1.56M 1.74% 19
2025
Q3
$5.29M Sell
44,110
-4,250
-9% -$519K 1.68% 20
2025
Q2
$6.48M Buy
48,360
+10,820
+29% +$1.22M 2.19% 18
2025
Q1
$3.5M Sell
37,540
-760
-2% -$72.3K 1.36% 24
2024
Q4
$3.41M Hold
38,300
1.18% 27
2024
Q3
$2.72M Buy
38,300
+9,450
+33% +$632K 0.98% 29
2024
Q2
$1.95M Hold
28,850
0.72% 30
2024
Q1
$1.75M Buy
+28,850
New +$1.63M 0.64% 38

Other funds holding NFLX

Altrafin AG's NFLX Position: Q2 2026 in Review

Altrafin AG reduced its Netflix (NFLX) stake by 40% in Q2 2026, selling an estimated $2.84M and leaving 47,504 shares worth $3.39M. The position accounts for 1.33% of the portfolio, ranked #23.

Altrafin AG first reported a position in NFLX in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.67M in Q1 2026. 3,370 funds tracked by Wall St. Rank hold NFLX as of Q2 2026.

  • Altrafin AG held 47,504 shares of Netflix worth $3.39M as of Q2 2026.
  • Altrafin AG sold 32,304 Netflix shares in Q2 2026, an estimated $2.84M.
  • Netflix made up 1.33% of Altrafin AG's portfolio in Q2 2026, its #23 holding.
  • Altrafin AG first reported a position in Netflix in Q1 2024 and has held it in 10 quarters since.
  • Altrafin AG's Netflix position peaked at $7.67M in Q1 2026.
  • 3,370 funds tracked by Wall St. Rank held Netflix as of Q2 2026.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.